Answer
It is licensed for specified previously treated locally advanced or metastatic breast cancer and unresectable advanced or metastatic liposarcoma in adults.
Sources for this answer
- Eribulin 0.44 mg/ml solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.